JP2013521285A5 - - Google Patents

Download PDF

Info

Publication number
JP2013521285A5
JP2013521285A5 JP2012556121A JP2012556121A JP2013521285A5 JP 2013521285 A5 JP2013521285 A5 JP 2013521285A5 JP 2012556121 A JP2012556121 A JP 2012556121A JP 2012556121 A JP2012556121 A JP 2012556121A JP 2013521285 A5 JP2013521285 A5 JP 2013521285A5
Authority
JP
Japan
Prior art keywords
aryl
pyridine
heterocyclyl
alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012556121A
Other languages
English (en)
Japanese (ja)
Other versions
JP5995728B2 (ja
JP2013521285A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/026399 external-priority patent/WO2011109254A1/en
Publication of JP2013521285A publication Critical patent/JP2013521285A/ja
Publication of JP2013521285A5 publication Critical patent/JP2013521285A5/ja
Application granted granted Critical
Publication of JP5995728B2 publication Critical patent/JP5995728B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012556121A 2010-03-04 2011-02-28 カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用 Expired - Fee Related JP5995728B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US31041010P 2010-03-04 2010-03-04
US61/310,410 2010-03-04
PCT/US2011/026399 WO2011109254A1 (en) 2010-03-04 2011-02-28 Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders

Publications (3)

Publication Number Publication Date
JP2013521285A JP2013521285A (ja) 2013-06-10
JP2013521285A5 true JP2013521285A5 (enExample) 2014-04-17
JP5995728B2 JP5995728B2 (ja) 2016-09-21

Family

ID=44542511

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012556121A Expired - Fee Related JP5995728B2 (ja) 2010-03-04 2011-02-28 カテコールo−メチルトランスフェラーゼの阻害剤および精神障害の治療におけるその使用

Country Status (12)

Country Link
US (2) US9024032B2 (enExample)
EP (1) EP2542076B1 (enExample)
JP (1) JP5995728B2 (enExample)
KR (1) KR101720824B1 (enExample)
CN (1) CN102869256B (enExample)
AU (1) AU2011223969B2 (enExample)
BR (1) BR112012021652A2 (enExample)
CA (1) CA2789471C (enExample)
ES (1) ES2862931T3 (enExample)
MX (1) MX2012010187A (enExample)
RU (1) RU2586974C2 (enExample)
WO (1) WO2011109254A1 (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2789471C (en) * 2010-03-04 2018-01-02 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
US9212147B2 (en) 2011-11-15 2015-12-15 Takeda Pharmaceutical Company Limited Dihydroxy aromatic heterocyclic compound
TWI638802B (zh) * 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
CN103845317B (zh) * 2012-11-28 2018-05-08 北京生命科学研究所 恩他卡朋在预防或治疗肥胖等代谢综合征中的应用
GB201222711D0 (en) 2012-12-17 2013-01-30 Takeda Pharmaceutical Novel compounds
CN104903300B (zh) * 2012-12-27 2018-04-17 霍夫曼-拉罗奇有限公司 Comt抑制剂
US9067917B2 (en) 2013-03-15 2015-06-30 Janssen Pharmaceutica Nv 1,2,5-substituted benzimidazoles as FLAP modulators
US9695149B2 (en) 2013-03-15 2017-07-04 Janssen Pharmaceutica Nv 1,2,6-substituted benzimidazoles as flap modulators
CN103588702B (zh) * 2013-10-26 2016-01-06 浙江大学 N-取代苯基吡啶-4-酮衍生物及其制备和应用
US9988373B2 (en) 2013-12-26 2018-06-05 Shionogi & Co., Ltd. Nitrogen-containing six-membered cyclic derivatives and pharmaceutical composition comprising the same
JP6858712B2 (ja) 2015-01-30 2021-04-14 リーバー インスティテュート フォー ブレイン ディベロップメントLieber Institute For Brain Development Comt阻害方法及び組成物
EP3287443B1 (en) 2015-04-24 2021-10-27 Shionogi & Co., Ltd 6-membered heterocyclic derivative and pharmaceutical composition comprising same
MA52119A (fr) 2015-10-19 2018-08-29 Ncyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
MY199220A (en) 2015-11-19 2023-10-20 Incyte Corp Heterocyclic compounds as immunomodulators
WO2017091818A1 (en) 2015-11-25 2017-06-01 Lieber Institute For Brain Development Comt inhibiting methods and compositions
CN105481812B (zh) * 2015-11-30 2020-04-21 重庆天奕恒化科技有限公司 一种5-苄氧基-4-氧代-4h-吡喃-2-羧酸的制备方法
JP6911031B2 (ja) 2015-12-22 2021-07-28 インサイト・コーポレイションIncyte Corporation 免疫調節剤としての複素環化合物
TW201808950A (zh) 2016-05-06 2018-03-16 英塞特公司 作為免疫調節劑之雜環化合物
US20170342060A1 (en) 2016-05-26 2017-11-30 Incyte Corporation Heterocyclic compounds as immunomodulators
MY197280A (en) 2016-06-20 2023-06-09 Incyte Corp Heterocyclic compounds as immunomodulators
EP3484866B1 (en) 2016-07-14 2022-09-07 Incyte Corporation Heterocyclic compounds as immunomodulators
MA46045A (fr) 2016-08-29 2021-04-28 Incyte Corp Composés hétérocycliques utilisés comme immunomodulateurs
US11066409B2 (en) 2016-10-17 2021-07-20 Shionogi & Co., Ltd. Bicyclic nitrogen-containing heterocyclic derivatives and pharmaceutical composition comprising the same
ES2899402T3 (es) 2016-12-22 2022-03-11 Incyte Corp Derivados de piridina como inmunomoduladores
BR112019012993A2 (pt) 2016-12-22 2019-12-03 Incyte Corporation derivados de benzo-oxazol como imunomoduladores
MA47099A (fr) 2016-12-22 2021-05-12 Incyte Corp Composés hétéroaromatiques bicycliques utilisés en tant qu'immunomodulateurs
PT3558990T (pt) 2016-12-22 2022-11-21 Incyte Corp Derivados de tetrahidroimidazo[4,5-c]piridina como indutores da internalização de pd-l1
US20180179201A1 (en) 2016-12-22 2018-06-28 Incyte Corporation Heterocyclic compounds as immunomodulators
CA3058111A1 (en) * 2017-03-31 2018-10-04 Fujifilm Corporation 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same
CN108191746B (zh) * 2018-02-02 2020-06-16 暨南大学 一种羟基吡啶酮类化合物及其制备方法与应用
HRP20230090T1 (hr) 2018-03-30 2023-03-17 Incyte Corporation Heterociklički spojevi kao imunomodulatori
HUE061503T2 (hu) 2018-05-11 2023-07-28 Incyte Corp Tetrahidro-imidazo[4,5-C]piridin-származékok mint PD-L1 immunmodulátorok
EP3876939A4 (en) 2018-11-07 2022-08-10 Dana-Farber Cancer Institute, Inc. Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereof
US11753406B2 (en) 2019-08-09 2023-09-12 Incyte Corporation Salts of a PD-1/PD-L1 inhibitor
PH12022550754A1 (en) 2019-09-30 2023-08-23 Incyte Corp Pyrido[3,2-d]pyrimidine compounds as immunomodulators
AU2020385113A1 (en) 2019-11-11 2022-05-19 Incyte Corporation Salts and crystalline forms of a PD-1/PD-L1 inhibitor
CN111170936B (zh) 2020-01-19 2021-01-01 杭州泽德医药科技有限公司 3,4-二羟基-n-(1’-苄基-2’-羟乙基)-2-甲基吡啶氯化物及制备和应用
US11691963B2 (en) 2020-05-06 2023-07-04 Ajax Therapeutics, Inc. 6-heteroaryloxy benzimidazoles and azabenzimidazoles as JAK2 inhibitors
KR102377058B1 (ko) 2020-11-04 2022-03-22 경북대학교 산학협력단 니아스텔라 코리엔시스에서 유래한 카테콜 o-메틸 트렌스퍼라제 및 이의 변이체
WO2022099018A1 (en) 2020-11-06 2022-05-12 Incyte Corporation Process of preparing a pd-1/pd-l1 inhibitor
MX2023005362A (es) 2020-11-06 2023-06-22 Incyte Corp Proceso para hacer un inhibidor de proteina de muerte programada 1 (pd-1)/ligando de muerte programada 1 (pd-l1) y sales y formas cristalinas del mismo.
TW202233615A (zh) 2020-11-06 2022-09-01 美商英塞特公司 Pd—1/pd—l1抑制劑之結晶形式
TW202241889A (zh) 2020-12-23 2022-11-01 美商雅捷可斯治療公司 作為jak2抑制劑之6-雜芳基氧基苯并咪唑及氮雜苯并咪唑
WO2023004291A1 (en) * 2021-07-19 2023-01-26 Baylor College Of Medicine Coronavirus main protease inhibitors and methods using same
AU2022388555A1 (en) 2021-11-09 2024-05-02 Ajax Therapeutics, Inc. 6-he tero aryloxy benzimidazoles and azabenzimidazoles as jak2 inhibitors
US12162881B2 (en) 2021-11-09 2024-12-10 Ajax Therapeutics, Inc. Forms and compositions of inhibitors of JAK2
CN114716366B (zh) * 2022-04-13 2023-12-26 浙江大学 3-羟基吡啶-4-酮类衍生物及在抑制肾细胞铁死亡中的应用
CN116947812B (zh) * 2023-06-30 2025-09-02 南京红太阳医药研究院有限公司 一种艾司奥美拉唑镁降解杂质的制备方法
WO2025257687A1 (en) * 2024-06-11 2025-12-18 Universidade Do Porto Hydroxypyridinone compounds as inhibitors of catechol-o-methyltransferase

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8811055D0 (en) * 1988-05-10 1988-06-15 Ici Plc Antibiotic compounds
US5336482A (en) * 1991-12-05 1994-08-09 The Du Pont Merck Pharmaceutical Company Technetium-99m complexes with N-substituted 3-hydroxy-4-pyridinones
FR2687674B1 (fr) * 1992-02-07 1995-05-19 Roussel Uclaf Nouveaux derives de la pyridone, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.
JP2001319486A (ja) 2000-05-12 2001-11-16 Mitsubishi Electric Corp 不揮発性半導体記憶装置
SE0004053D0 (sv) * 2000-11-06 2000-11-06 Astrazeneca Ab N-type calcium channel antagonists for the treatment of pain
SI1441735T1 (sl) * 2001-10-26 2006-06-30 Angeletti P Ist Richerche Bio N-substituirani hidroksipirimidinon-karboksamidniinhibitorji HIV-integraze
US8455489B2 (en) * 2003-11-10 2013-06-04 Exelixis, Inc. Substituted pyrimidine compositions and methods of use
JP2007126716A (ja) * 2005-11-04 2007-05-24 Miyazaki Tlo:Kk カドミウムに対する亜鉛の高選択的抽出剤及び亜鉛の回収
US7834050B2 (en) * 2006-03-29 2010-11-16 Duke University Small molecule insulin mimetics absent quinones
JP2009234959A (ja) * 2008-03-26 2009-10-15 Pias Arise Kk 3−ヒドロキシ−2−メチル−1−フェニル−4−ピリジノン又はその誘導体からなる美白剤、並びにその美白剤を含有する美白用皮膚外用剤、化粧料
CA2789471C (en) * 2010-03-04 2018-01-02 Merck Sharp & Dohme Corp. Inhibitors of catechol o-methyl transferase and their use in the treatment of psychotic disorders

Similar Documents

Publication Publication Date Title
JP2013521285A5 (enExample)
RU2012142194A (ru) Ингибиторы катехол-о-метилтрансферазы и их применение при лечении психотических расстройств
AU2009278442B2 (en) Imidazopyridin-2-one Derivatives
RU2443706C2 (ru) Фармацевтические соединения
JP2011527684A5 (enExample)
JP2013521288A5 (enExample)
ME02203B (me) Hinolin i hinoksalin derivati kao inhibitori kinaza
RU2665036C9 (ru) Гетероароматические соединения-модуляторы фосфоинозидит-3-киназы и способы применения
HRP20240368T1 (hr) Heterociklički inhibitori atr kinaze
JP2020527174A5 (enExample)
RU2018123779A (ru) Новые соединения
AU2012351342A1 (en) Combination of CRTH2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis
WO2008064255A2 (en) Compounds modulating c-fms and/or c-kit activity and uses therefor
JP2019536768A5 (enExample)
NZ586579A (en) Fused heterocyclic derivatives and methods of use as c-met inhibitors
EP3010503A2 (en) Novel bicyclic bromodomain inhibitors
JP2016164184A5 (enExample)
HRP20191937T1 (hr) Derivati heksahidropirolo [3,4-c]pirola i srodni spojevi kao inhibitori autotaksina (atx) i kao inhibitori proizvodnje lizofosfatidne kiseline (lpa) za liječenje npr. bubrežnih bolesti
JP2014528479A5 (enExample)
JP2013537210A5 (enExample)
RU2007112110A (ru) Производные пирроло[2.3-с] пиридина и способы их получения
JP2017504311A5 (enExample)
JP2014533734A5 (enExample)
HRP20110804T1 (hr) Benzocikloheptapiridini kao inhibitori receptora tirozin kinaze met
HRP20192197T2 (hr) Derivati karbazola